We turn your breeding strategy into a decision-ready business case, in the financial language your board, investors or funders already trust.
Unlike feed or management spend, genetic gain is permanent and cumulative. Each generation of improvement becomes the new floor, and it spreads across the whole population. The challenge is often not the science, but translating index points into financial terms a board can assess.
Your breeding strategy, translated into the language of investment.
Build a credible "do nothing" case from your own data, so reviewers can see what the investment is expected to deliver.
Convert genetic gain into money earned or saved, and illustrate how it may compound over time.
Report NPV, IRR, payback period or benefit-cost ratio, matched to your audience.
Assess biological, market and delivery risk, and consider staging the spend to demonstrate returns early.
We agree the decision and audience, which sets the evidence and metrics that matter.
We build the "do nothing" case. The gap indicates what the investment may deliver.
We estimate the value of the gain and how it compounds over a realistic horizon.
We put costs and value on one discounted timeline, in the metrics your audience trusts
We test the risk, assess how the case holds and advise on a staged way forward.
A decision-ready business case
A financial model with NPV, IRR and payback
Risk scenarios and a staged funding plan
A presentation for your board, investors or funders
Tell us about your animals and your goals. We will suggest where to start.